B.Pharm Lab. Instruction Manuals

Pharmacology I

APHE Anatomy, Physiology, and Health Education

Pharmaceutical Analysis

Pharmacy study material

Bones and Skeleton System

Bone disease (Gout) (Rheumatoid arthritis) (Osteoarthritis) (Osteoporosis)

Cancer and music therapy

Memory of water

Dosage and monitoring tests for anti-rheumatoid drugs

Sodium aurothiomalate

Common mechanism of action

Acts by inhibiting prostaglandins, MHC, IL-1.

Major adverse drug reactions (ADRs)

SLE, renal or hepatic disorders, haematological disorder.

Monitoring test

Baseline and until stable: UA, CBC with platelets preinjection, Same as initial if dose is changed.


IM: 10-mg test dose, then weekly dosing 25-50 mg; dosing interval may increase after response.


Common mechanism of action

Acts as immunosuppressant.

Major adverse drug reactions (ADRs)

Bone marrow suppression, immunocompromization.

Monitoring test

CBC with platelets, AST every 2 weeks for 1-2 months followed by every 1-2 months.


Oral: 50-150 mg daily.

< Prev.Page   1   2   3   4  5  6   7   8   9   10  11  12   13   Next page>